Last reviewed: May 1, 2026
Listen now
Episode breakdown
Key takeaways
- Beyond regulatory approval, MedTech companies must demonstrate a device's value proposition across affordability, care quality, operational impact, and long-term value.
- Market selection is a critical commercialization factor, as reimbursement models and care delivery systems significantly differ between countries like the United States, the UK, Germany, and the Netherlands.
- A strong adoption case for medical devices requires evidence that extends beyond narrow technical performance data.
- Understanding economic logic across diverse healthcare markets is essential for successful MedTech product launches.
- The efficacy of a medical device in one regulatory environment does not guarantee commercial success or equivalent fit in others due to varying healthcare infrastructures.
A device can clear regulatory hurdles and still struggle commercially if the evidence is too narrow. MedTech companies need proof that speaks to affordability, care quality, operational impact, and long term value, not just technical performance.
Market selection matters just as much. The same solution may fit the United States, the UK, Germany, or the Netherlands very differently because reimbursement models, provider incentives, and care delivery systems are not built the same way.
Frequently asked questions
More episodes
Keep listening
-
Episode 69
Science Before Hype in MedTech Investing with Varun Turlapati of Chaanakya Capital
With Varun Turlapati
-
Episode 67
De-Risking Product Decisions in MedTech Startups with Brent Lavin of Ironwood MedTech Partners
With Brent Lavin
-
Episode 66
Vibe Coding Security Risks and Malicious Code Injection with Jake Rodriguez of Triangle Tech
With Jake Rodriguez
-
Episode 65
Why Clinical Trials Are the Most Expensive Capital Outlay for Startups with Rob Bedford, CEO of Franklyn Health
With Rob Bedford